Target intelligence / Profile preview

Streptococcus pneumoniae Capsular Polysaccharide Antigens (CPS)

Target
CPS
Molecular classification
Polysaccharide, Bacterial Surface Antigen, Capsular Polysaccharide
01

Overview

Streptococcus pneumoniae capsular polysaccharide antigens are complex carbohydrate structures forming the outermost layer of S. pneumoniae. These are major virulence factors, enabling immune evasion. There are 98 recognized serotypes based on structural differences. These antigens are the primary targets for pneumococcal vaccines. Capsular polysaccharides act as T-cell-independent antigens. Current pneumococcal vaccines use purified or conjugated forms of these antigens from selected serotypes, providing serotype-specific protection. They are also used in diagnostic assays to identify specific pneumococcal serotypes.

Other names
Pneumococcal Capsular PolysaccharideS. pneumoniae Capsular PolysaccharidesCapsular Polysaccharide AntigensPneumococcal CPS
02

Mechanism of action

Active immunization via antibody production against specific serotypes, leading to opsonophagocytosis and complement-mediated killing of bacteria expressing the corresponding capsular polysaccharide.

03

Biological functions

Evasion of phagocytosisImmune evasionColonization of mucosal surfacesVirulence factorBacterial capsule formation
04

Disease associations

PneumoniaMeningitisBacteremiaOtitis mediaSinusitisInfection
05

Safety considerations

Serotype replacement (shift in prevalence toward non-vaccine serotypes)Limited protection to serotypes not included in the vaccinePotential for cross-reactivity with commensal streptococci
06

Interacting drugs

Pneumococcal vaccines (e.g., PCV13, PPSV23)
07

Biomarkers

Capsular polysaccharide serotype for vaccine selectionAntibody titers against specific capsular polysaccharides for assessing vaccine efficacy

Beyond the preview

Go deeper on Streptococcus pneumoniae Capsular Polysaccharide Antigens (CPS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcus pneumoniae Capsular Polysaccharide Antigens (CPS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call